Samjin Pharm (005500) — Capital Reinvestment Ratio
Samjin Pharm (005500) has a Capital Reinvestment Ratio of 0.36x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.63 Billion) in capital expenditures (₩3.78 Billion). See Samjin Pharm balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Samjin Pharm Capital Reinvestment Ratio (2013–2024)
This chart tracks Samjin Pharm's Capital Reinvestment Ratio across 12 annual periods. Check cash flow reinvestment rate of Samjin Pharm to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Samjin Pharm (2013–2024)
Year-by-year Capital Reinvestment Ratio for Samjin Pharm from 2013 to 2024. For live market cap and broader valuation context, see 005500 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.48x | ₩38.15 Billion | ₩18.34 Billion | ▼ -80.7% |
| 2023 | 2.49x | ₩8.33 Billion | ₩20.72 Billion | ▲ +21.1% |
| 2022 | 2.05x | ₩17.29 Billion | ₩35.50 Billion | ▼ -34.1% |
| 2021 | 3.11x | ₩23.97 Billion | ₩74.60 Billion | ▲ +142.7% |
| 2020 | 1.28x | ₩23.86 Billion | ₩30.60 Billion | ▲ +151.7% |
| 2019 | 0.51x | ₩23.63 Billion | ₩12.04 Billion | ▲ +86.1% |
| 2018 | 0.27x | ₩30.08 Billion | ₩8.24 Billion | ▲ +15.2% |
| 2017 | 0.24x | ₩37.28 Billion | ₩8.86 Billion | ▲ +48.3% |
| 2016 | 0.16x | ₩48.66 Billion | ₩7.80 Billion | ▼ -60.4% |
| 2015 | 0.40x | ₩18.94 Billion | ₩7.66 Billion | ▼ -1.8% |
| 2014 | 0.41x | ₩32.41 Billion | ₩13.35 Billion | ▼ -55.5% |
| 2013 | 0.93x | ₩7.37 Billion | ₩6.83 Billion | — |